HB
Helix BioPharma Corp.
HBPCF · OTC
$1.71 +0.00% (+$0.00)
Market Cap $179.9M
P/E Ratio -
Div. Yield -
ROE 21.90%
Bulios Fair Price
$1
41.5% downside
Trenutna cena
$1.71
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HBPCF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 12.25x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 264.91%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 15.78%
ROIC 22.04%
Asset turnover 0.00x
Debt
47 /100
Moderate Int. coverage -130.06x
Debt/Equity 0.02x
Current ratio 0.45x
Stability
39 /100
Moderate Profitable years 0
Beta -0.35x
EPS volatility 42.79%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HBPCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas Mehrling
Employees
7
Headquarters
Vancouver
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report